Informações:
Falhas:
ID
34825
Descrição
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02461602
Link
https://clinicaltrials.gov/show/NCT02461602
Palavras-chave
Versões (1)
- 30/01/2019 30/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
30 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Atrial Fibrillation NCT02461602
Eligibility Atrial Fibrillation NCT02461602
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT02461602
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
18 years or older at the time of enrollment
boolean
C0001779 (UMLS CUI [1])
Atrial Fibrillation Electrocardiography
Item
electrocardiographically confirmed af
boolean
C0004238 (UMLS CUI [1,1])
C1623258 (UMLS CUI [1,2])
C1623258 (UMLS CUI [1,2])
Surveys Completion
Item
able to complete patient-reported outcomes surveys
boolean
C0038951 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,2])
Warfarin therapy started
Item
initiated warfarin therapy in the prior 3 months
boolean
C0419974 (UMLS CUI [1])
Adherence Clinic Visits
Item
ability to adhere to regular clinical visits
boolean
C1510802 (UMLS CUI [1,1])
C0008952 (UMLS CUI [1,2])
C0008952 (UMLS CUI [1,2])
Informed Consent
Item
ability to sign informed consent
boolean
C0021430 (UMLS CUI [1])
Able to read English Language | Comprehension English Language | Able to speak English Language
Item
ability to read/comprehend/speak english
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0233733 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0564215 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
C0376245 (UMLS CUI [1,2])
C0233733 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0564215 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
Life Expectancy
Item
anticipated life expectancy less than six months (as determined by the site investigator)
boolean
C0023671 (UMLS CUI [1])
Atrial Fibrillation Transient | Secondary to Condition Reversible | Hyperthyroidism | Pulmonary Embolism | Status post Cardiothoracic surgery
Item
transient af secondary to a reversible condition (hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery)
boolean
C0004238 (UMLS CUI [1,1])
C0205374 (UMLS CUI [1,2])
C0175668 (UMLS CUI [2,1])
C0348080 (UMLS CUI [2,2])
C0205343 (UMLS CUI [2,3])
C0020550 (UMLS CUI [3])
C0034065 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C2242990 (UMLS CUI [5,2])
C0205374 (UMLS CUI [1,2])
C0175668 (UMLS CUI [2,1])
C0348080 (UMLS CUI [2,2])
C0205343 (UMLS CUI [2,3])
C0020550 (UMLS CUI [3])
C0034065 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C2242990 (UMLS CUI [5,2])
Deep Vein Thrombosis | Pulmonary Embolism
Item
recent dvt or pe (within 6 months)
boolean
C0149871 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
C0034065 (UMLS CUI [2])
Study Subject Participation Status | Anticoagulation Therapy Atrial Fibrillation
Item
participation in a randomized trial of anticoagulation for af
boolean
C2348568 (UMLS CUI [1])
C0003281 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
C0003281 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
Use of Home INR Monitoring Services
Item
use of a home inr monitoring system
boolean
C1524063 (UMLS CUI [1,1])
C4523608 (UMLS CUI [1,2])
C4523608 (UMLS CUI [1,2])